Study guide
9.2 Acute Respiratory Failure and ARDS
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
9.2 Acute Respiratory Failure and ARDS
Key Takeaways Explain This Topic AI
Shunt is the only mechanism of hypoxemia that fails to correct with supplemental oxygen; refractory hypoxemia on 100% oxygen requires positive pressure and recruitment, not a higher FiO2.
ARDS severity by P/F ratio with PEEP of 5 cmH2O or more: mild 200-300, moderate 100-200, severe 100 or less; the diagnosis requires that the failure is not fully explained by cardiac failure or fluid overload, which does not mean heart failure must be absent.
Tidal volume is 4-6 mL/kg of predicted body weight (men 50 + 2.3 x (inches - 60); women 45.5 + 2.3 x (inches - 60)), with plateau pressure 30 cmH2O or less and driving pressure 15 cmH2O or less.
Permissive hypercapnia raises pulmonary vascular resistance and precipitates acute cor pulmonale in 20-25% of moderate-to-severe ARDS - a far greater risk in patients with pre-existing pulmonary hypertension or RV dysfunction.
Prone positioning for at least 16 hours per day when the P/F ratio is under 150 reduced 28-day mortality from 32.8% to 16.0% in PROSEVA; VV-ECMO provides gas exchange only, while VA-ECMO provides circulatory support.
Last updated: August 2026
Two Kinds of Failure, Five Mechanisms of Hypoxemia
Test-plan item II.A.2 asks you to reason about oxygenation and ventilation failure in a patient whose heart is also the problem. Start with the two-category framework:
Type I (hypoxemic) respiratory failure: PaO2 under 60 mmHg on room air with a normal or low PaCO2. This is a lung/oxygen-transfer problem — cardiogenic pulmonary edema, ARDS, pneumonia, PE, atelectasis after sternotomy.
Type II (hypercapnic) respiratory failure: PaCO2 above 45-50 mmHg with pH under 7.35. This is a pump/drive/load problem — opioid and sedative excess after cardiac procedures, obesity hypoventilation, neuromuscular weakness, COPD with an acute exacerbation, or exhaustion after prolonged work of breathing.
Both may be present. A heart failure patient with flash pulmonary edema starts hypoxemic and hypocapnic, then becomes hypercapnic as respiratory muscles fatigue — a rising PaCO2 in a tachypneic patient who was previously blowing off CO2 is a pre-intubation finding , not reassurance.
The Five Mechanisms of Hypoxemia
Mechanism A-a gradient Corrects with 100% oxygen? Cardiac-unit examples
Shunt (perfusion without ventilation) Increased No — this is the discriminator ARDS, flash pulmonary edema, lobar atelectasis after CABG, pneumonia consolidation, right-to-left intracardiac shunt through a patent foramen ovale
V/Q mismatch Increased Yes, readily Pulmonary embolism, COPD, pleural effusion, mucus plugging, early edema
Diffusion limitation Increased Yes Interstitial lung disease, chronic pulmonary vascular disease, high output states
Hypoventilation Normal Yes Opioid or benzodiazepine excess, residual anesthesia, obesity hypoventilation, neuromuscular disease
Low inspired oxygen tension Normal Yes Altitude, gas-supply error — rare in hospital
Shunt does not correct with supplemental oxygen because blood bypassing ventilated alveoli never contacts oxygen at any FiO2. That single fact answers a great many CMC items. Clinically: a patient on 100% via non-rebreather with a PaO2 of 55 mmHg has a shunt, and increasing the FiO2 further will not help — positive pressure (CPAP, BiPAP or intubation with PEEP) to recruit collapsed or flooded alveoli is what fixes it.
A uniquely cardiac version: platypnea-orthodeoxia , hypoxemia that worsens when the patient sits upright, caused by right-to-left shunting through a patent foramen ovale when right atrial pressure rises (RV infarction, PE, pulmonary hypertension, or after pneumonectomy). It is refractory to oxygen and is diagnosed with a bubble study, not a chest CT.
ARDS: The Definition and the Numbers
Acute respiratory distress syndrome (ARDS) is defined by the Berlin criteria, extended by the 2023 global definition. All four elements are required:
Timing: within 1 week of a known clinical insult or of new or worsening respiratory symptoms.
Imaging: bilateral opacities on chest radiograph or CT not fully explained by effusions, lobar/lung collapse, or nodules . The global definition also accepts bilateral B-lines and/or consolidation on lung ultrasound.
Origin of edema: respiratory failure not fully explained by cardiac failure or fluid overload . If no ARDS risk factor is present, an objective assessment such as echocardiography is required to exclude hydrostatic edema. Note the wording: "not fully explained by" — heart failure and ARDS routinely coexist, and the presence of a low ejection fraction does not exclude ARDS.
Oxygenation: the PaO2/FiO2 (P/F) ratio measured with PEEP or CPAP of 5 cmH2O or more.
- Severity P/F ratio (with PEEP or CPAP 5 cmH2O or greater) Approximate mortality
- Mild 200 to 300 27-35%
- Moderate 100 to 200 32-40%
- Severe 100 or less 45% or higher
The 2023 global definition adds a non-intubated category for patients on high-flow nasal oxygen at 30 L/min or more, and permits SpO2/FiO2 of 315 or less (when SpO2 is 97% or less) as a substitute for the P/F ratio when arterial blood gases are unavailable.
Cardiogenic Pulmonary Edema versus ARDS
- Feature Cardiogenic pulmonary edema ARDS
- Onset Minutes to hours 6 hours to 7 days after an insult
Pulmonary artery occlusion pressure Above 18 mmHg 18 mmHg or less, typically 15 or less (not a formal criterion)
Cardiac output / SvO2 Low output, low SvO2 Normal or high output, normal or high SvO2 unless septic
Chest radiograph Perihilar "bat wing" pattern, vascular cephalization, Kerley B lines, cardiomegaly, bilateral effusions Peripheral patchy or diffuse opacities, normal heart size, air bronchograms, fewer effusions
- BNP / NT-proBNP Markedly elevated (BNP typically above 500 pg/mL) Often lower, but not discriminating alone
- Edema fluid protein / serum protein Below 0.65 (transudate — hydrostatic) Above 0.75 (exudate — permeability)
Echocardiography Reduced EF or elevated filling pressures, E/e-prime above 14, dilated non-collapsing IVC Preserved LV function with normal filling pressures
Response to diuresis and afterload reduction Rapid improvement Little immediate change
The CMC-level judgment is that these are not mutually exclusive: the patient with an EF of 30% and aspiration pneumonitis has both, and the treatment must satisfy both — enough diuresis to relieve hydrostatic congestion without so much that cardiac output falls.